0001127602-12-002987.txt : 20120130 0001127602-12-002987.hdr.sgml : 20120130 20120130164125 ACCESSION NUMBER: 0001127602-12-002987 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120126 FILED AS OF DATE: 20120130 DATE AS OF CHANGE: 20120130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAGEMANN ROBERT CENTRAL INDEX KEY: 0001222676 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 12556096 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0304 4 2012-01-26 0001022079 QUEST DIAGNOSTICS INC DGX 0001222676 HAGEMANN ROBERT C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 SVP & Chief Financial Officer Common Stock 2012-01-26 4 M 0 113334 52.235 A 253009 D Common Stock 2012-01-26 4 S 0 100604 59.0918 D 152405 D Common Stock 2012-01-26 4 S 0 12730 59.6543 D 139675 D Common Stock 1772 I SDCP Stock Options (Right to Buy) 52.235 2012-01-26 4 M 0 113334 0 D 2013-02-15 Common Stock 113334 0 D The options vested in three annual installments with the first on February 15, 2007, the second on February 15, 2008 and the final on February 15, 2009. This transaction was executed in multiple trades at prices ranging from $58.60 to $59.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $59.60 to $59.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The amount includes exempt purchases made under the Company's stock purchase plan. These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann 2012-01-30